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Erythema migrans is the skin manifestation of Lyme 
disease and southern tick-associated rash illness. Neither 
disease is found in the Caribbean. We report 4 cases of 
erythema migrans of a possible emerging clinical entity, Ca-
ribbean erythma migrans–like illness.
E
rythema migrans (EM), the pathognomonic rash for 
Lyme disease (LD), occurs in ≈90% of cases (1). Dur-
ing the past 30 years, an LD-like illness has been described 
in the southeastern and south-central United States (2). 
This illness resembles LD clinically, but patients show no 
evidence of infection with the etiologic agent of LD, Bor-
relia burgdorferi (2) or sequelae of LD (2). This clinical 
syndrome is called southern tick-associated rash illness 
(STARI). The vector for STARI is not found in the Carib-
bean. However, we report 4 cases of EM-like lesions in 
Caribbean Island residents.
Case Reports
In October 2007, a 28-year-old man (student) sought 
care for a rash of 6 months’ duration and generalized joint 
pains of a few days’ duration. He had a history of major 
depression but was not taking medication. He reported be-
ing well until 6 months earlier, when he noticed a rash on 
his left leg. It began as a lesion on his thigh and spread 
throughout his entire left lower limb and upper limbs. He 
had no other symptoms.
The patient’s joints showed no signs of inﬂ  ammation. 
On his left outer thigh was a large lesion (8 cm × 5 cm) 
with many similar lesions 1–5 cm in diameter, with central 
clearing on the rest of his lower limb and upper limb (Fig-
ure 1). No punctum was evident in any lesion. Two visits 
to a dermatologist resulted in prescriptions for topical keto-
conazole and beclomethasone, which had no effect on the 
rash. A skin biopsy was eventually performed.
The patient grew up in St. Lucia but had traveled to 
Trinidad and Tobago 3 years earlier. In St. Lucia, he owned 
several tick-infested dogs. In 2005, he had spent 2 weeks in 
New York, New York, USA. He did not recall being bitten 
by ticks in either place.
Because of the rash and the exposure to ticks, a tick-
borne illness was considered. Serologic analysis for B. 
burgdorferi and histologic analysis of a skin biopsy speci-
men were undertaken, and the patient was treated with 
doxycycline, 100 mg 2×/d for 2 weeks. Within 1 week, 
his arthralgia disappeared, and by week 2, the rash had re-
solved. At 6-month follow-up, the rash had not recurred.
Results for immunoglobulin (Ig) M and IgG to B. 
burgdorferi by enzyme immunoassay and the C6 peptide 
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Figure 1. Erythema migrans–like rash on the left leg of a 28-year-
old patient. A) Characteristic rash of erythema migrans (annular 
macular lesion that is erythematous with central clearing). B) 
Spread of the lesions to the rest of the leg.antibody were negative. Histologic analysis of the skin bi-
opsy specimen showed perivascular lymphocytic inﬁ  ltrates 
with admixture of plasmocytes, consistent with EM (Figure 
2). Culture and silver staining for spirochetes were not per-
formed. On the basis of the clinical ﬁ  ndings and negative 
serologic results for B. burgdorferi, an EM-like illness was 
diagnosed.
In March 2008, a 15-year-old boy from Trinidad and 
Tobago sought care for a red pruritic rash of 4 weeks’ du-
ration. Atopic eczema had been diagnosed 1 year earlier. 
Atopic eczema was again diagnosed and topical steroid 
cream prescribed, but the rash persisted. On examination 
in April 2008, the rash was present on his arms and legs. 
Multiple lesions 1–6 cm in diameter all had an erythematic 
border with central clearing. Histologic ﬁ  ndings on skin bi-
opsy were consistent with EM. After treatment with doxy-
cycline for 14 days, the rash cleared. After 1 year, it had 
not recurred.
In April 2009, a 60-year-old woman from Grenada 
with diabetes sought care for an ongoing pruritic rash of 
4–6 months’ duration. The rash had an erythematous, ﬂ  at 
border with a central clearing 7 cm in diameter but no 
punctum. It occurred only on her legs, ﬁ  rst the left, then the 
right. Visits to several doctors resulted in prescriptions for 
vitamin A, vitamin E, and steroid and antifungal creams, 
all of which partially cleared the rash. She had no history of 
recent inﬂ  uenza-like symptoms or neurologic complaints. 
EM was diagnosed in October by biopsy. After treatment 
with doxycycline for 7 days, the rash resolved and had not 
recurred after 1 year.
In January 2010, a 48-year-old woman (veterinary lab-
oratory assistant) from Trinidad and Tobago sought care 
for a circular, erythematic rash of 2 weeks’ duration. The 
rash started on her right leg; had a ﬂ  at, erythematous bor-
der with central clearing; and progressively increased to 5.1 
cm in diameter. There was no evidence of a punctum. Two 
similar 2–3-cm lesions on her left leg appeared 3 days after 
the ﬁ  rst lesion. She also reported fatigue, mild body and 
joint pains, and headaches relieved by acetaminophen. She 
had no history of travel to an LD-endemic region. EM was 
diagnosed and treatment with doxycyline was started. The 
rash began clearing after 2 weeks of treatment and had not 
recurred after 4 months.
Conclusions
STARI is characterized by expanding annular erythema, 
mild constitutional symptoms, spring–summer seasonality, 
recent antecedent tick bite at the site of the skin rash, ab-
sence of B. burgdorferi antibodies, and negative skin biopsy 
culture results for B. burgdorferi (2). Because none of our 
patients recalled an antecedent tick bite or had a punctum, 
their illnesses failed to meet the criteria for STARI.
In a prospective clinical evaluation of EM, lesions in 
STARI patients from Missouri were substantially smaller and 
more likely to have central clearing, and patients had a lower 
mean symptom score, compared with LD patients in a New 
York study (3). Although clinical ﬁ  ndings of our patients 
were comparable with those of the Missouri STARI patients, 
our patients’ multiple, widespread, and oblong lesions with 
no punctum and lack of known histories of tick bite were 
comparable with those of New York LD patients (3).
Unlike LD, for which Ixodes spp. ticks are the vector, 
STARI is thought to be spread by the Lone Star tick (Am-
bylomma americanum), the most common tick parasitizing 
humans in the southeastern and south-central United States 
(4). It is not an effective carrier of B. burgdorferi; however, 
2% of the species are infected with another spirochete, B. 
lonestari (5). In 1 isolated case, B. lonestari was identiﬁ  ed 
by PCR as the etiologic agent of STARI (6). In another 
report, no evidence of B. lonestari infection was found in 
30 cases studied (7).
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Figure 2. Histologic analysis of a skin biopsy specimen of a 28-
year-old patient with erythema migrans, showing characteristics of 
erythema migrans. The epidermis shows parakeratosis, microvesicle 
formation, lichenoid interface, dermal edema, and perivascular 
chronic inﬂ  ammatory cell inﬁ  ltrates. Original magniﬁ  cation ×20 (A) 
and ×40 (B).Erythema Migrans–like Illness in the Caribbean
EM also has been associated with other infectious 
agents. In an imported human African trpanosomiasis case 
in France, the skin lesion resembled EM (8). In a study in 
Spain (9),  Dermacentor marginatus ticks infected with 
Rickettsia slovaca produced EM-like rash and lymphade-
nopathy in 22 patients studied. In addition, EM has been 
reported as a skin manifestation in Rocky Mountain spotted 
fever (10). EM can no longer be considered solely a sign of 
borrelial infection.
A. americanum ticks occur mainly in North America 
and certain areas of Mexico (11). A. americanum ticks and 
the LD vectors (I. scapularis and I. paciﬁ  cus ticks) are not 
found in the Caribbean (11). The vector for the EM-like rash 
in our cases is therefore unlikely to be that of either STARI 
or LD. Other Ambylomma spp. ticks, however, have been 
found in Trinidad and Tobago (12). Whether these species 
are potential vectors for EM remains unknown; therefore, 
whether we are describing a new entity, Caribbean erythe-
ma migrans–like illness, remains to be determined.
We report EM-like skin lesions in 4 Caribbean nation-
als who did not have foreign exposure to ticks. The vectors 
for STARI and LD are not known to exist in the Caribbean 
region. Further research is warranted to isolate the respon-
sible vector and etiologic agent.
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